Keymed Biosciences Co.ltd

This study tested a new medicine called CM310 in 180 teenagers with moderate-to-severe eczema (atopic dermatitis). The goal was to see if it could clear skin and reduce itching better than a placebo. Results showed that more teens using CM310 had significant skin improvement by w…

This early-stage study tested a new medicine called CM512 in 110 healthy volunteers and people with moderate to severe eczema (atopic dermatitis). The main goal was to check if the drug is safe and how the body handles it. Participants received either the drug or a placebo, and r…